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Strains of Shiga toxin-producing Escherichia coli (STEC) are a serious threat to the
health, with approximately half of the STEC related food-borne illnesses attributable
to contaminated beef. We developed an assay that was able to screen samples for
several important STEC associated serogroups (O26, O45, O103, O104, O111, O121,
O145, O157) and three major virulence factors (eae, stx1, stx2) in a rapid and multiplexed
format using the Multiplex oligonucleotide ligation-PCR (MOL-PCR) assay chemistry. This
assay detected unique STEC DNA signatures and is meant to be used on samples from
various sources related to beef production, providing a multiplex and high-throughput
complement to the multiplex PCR assays currently in use. Multiplex oligonucleotide
ligation-PCR (MOL-PCR) is a nucleic acid-based assay chemistry that relies on flow
cytometry/image cytometry and multiplex microsphere arrays for the detection of nucleic
acid-based signatures present in target agents. The STEC MOL-PCR assay provided
greater than 90% analytical specificity across all sequence markers designed when
tested against panels of DNA samples that represent different STEC serogroups and
toxin gene profiles. This paper describes the development of the 11-plex assay and
the results of its validation. This highly multiplexed, but more importantly dynamic and
adaptable screening assay allows inclusion of additional signatures as they are identified
in relation to public health. As the impact of STEC associated illness on public health is
explored additional information on classification will be needed on single samples; thus,
this assay can serve as the backbone for a complex screening system.
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INTRODUCTION
Shiga toxin-producing E. coli (STEC) is an important foodborne
pathogen that caused an estimated 2.8million illnesses, 3890
cases of acute kidney failure (hemolytic uremic syndrome)
(HUS), and 230 deaths worldwide in 2012 (Majowicz et al.,
2014). In the United States, STEC O157:H7 is responsible for the
majority of these cases, and caused an estimated 4928 human
infections per year from 2003 to 2012 (Heiman et al., 2015).
In addition to more severe manifestations of infection like
HUS, human infections can also be as mild as watery diarrhea
progressing to hemorrhagic colitis (HC), manifested clinically as
bloody diarrhea. Ingestion of food contaminated with STEC is
one of the pathways to human STEC infection. The two most
common food sources of STEC infection are beef products and
leafy vegetables (1144 and 922 reported illnesses, respectively,
from 2003 to 2012) (Heiman et al., 2015). STEC O157:H7, shed
in cattle feces, is a major source of environmental contamination,
including that of waterways near feedlots. Vegetable cultivation
and processing operations utilizing these fecal contaminated
waterways lead to points of STEC contamination for leafy greens
and other produce (Cooley et al., 2014; Heiman et al., 2015). In
addition to STEC O157:H7, infections with non-O157:H7, and
in particular serogroups O26, O45, O103, O111, O121, O145
increased in the U.S. during 2000–2010 (Gould et al., 2013).
Further, between May-July 2011, outbreaks of HC and HUS
occurred in Europe due to a newly emergent STEC serotype
identified as O104:H4 (European Food Safety Authority, 2011;
Grad et al., 2012). While STEC serotype O104:H4 has not been
found in cattle in the U.S. (Shridhar et al., 2016) and its reservoir
has not been determined, it still presents a threat to human
health. Thus, within a short span of time, a significant number
of serogroups of concern have been identified.
Shiga toxin (Stx), also known as Vero cytotoxin and formerly
as Shiga-like toxin, is produced by STEC as one of two
antigenically distinct types, Stx1 or Stx2, encoded, respectively,
by stx1 and stx2 (Scheutz et al., 2012; Melton-Celsa, 2014).
Within Stx1 and Stx2, subtypes representing amino acid sequence
variants with varying types or levels of toxicity, biological activity,
and immunological distinction are recognized (Scheutz et al.,
2012; Melton-Celsa, 2014). Stx inhibits protein synthesis in
susceptible host cells and species, e.g., endothelial cells in humans
(Ferens and Hovde, 2011). The subtypes of Stx1 include Stx1a,
Stx1c, Stx1d; those of Stx2 include Stx2a, Stx2b, Stx2c, Stx2d,
Stx2e, Stx2f, and Stx2g. Using this nomenclature, the toxins
originally named Stx1 and Stx2 are Stx1a and Stx2a, encoded by
stx1a and stx2a, respectively.
STEC strains, by definition, produce Stx or at least carry stx,
but those causing disease in human patients have additional
virulence factors required for pathogenesis. A subset of STEC
known as enterohemorrhagic E. coli (EHEC) are positive for
both stx and eae, or are stx-positive but eae-negative and yet
have been isolated from patients with hemorrhagic colitis and/or
HUS (Croxen et al., 2013). The eae gene encodes for intimin,
the protein responsible for intimate attachment to the host
cell membrane through its binding to the translocated intimin
receptor (Croxen et al., 2013). Those EHEC strains lacking eae
colonize the human intestine via adhesins other than intimin
(Croxen et al., 2013). STEC classification into serogroups is
provided by O (lipopolysaccharide) and H (flagellar) antigens.
EHEC strains of the seven major serogroups that cause disease
in the U.S. (i.e., O26, O45, O103, O111, O121, O145, and O157)
have been classified as adulterants in raw, non-intact beef by
the U.S. Department of Agriculture, Food Safety and Inspection
Service (FSIS) (Stromberg et al., 2016). In the present study,
we will refer to EHEC of these seven serogroups together with
O104:H4 as STEC-8.
The current state of the art in molecular diagnostics for
STEC-8 detection is multiplex PCR (real time or end point).
This assay chemistry identifies STEC serogroups by detecting
unique DNA sequences for genes expressed in the O-antigen
gene clusters of the genomic DNA (Perelle et al., 2004; DebRoy
et al., 2011; Bai et al., 2012). Multiplex real-time PCR (Noll
et al., 2015) detection assays are able to detect a variety
of genes that determine serogroup and virulence in a single
sample (Wang et al., 2002), but are limited to a single reaction
multiplex level of 3–4 unique sequences. In contrast, higher level
end point multiplex-PCR single reaction nucleic acid detection
assays have sample throughput limitations due to constraints
of analysis technology (pulse field gel electrophoresis, capillary
electrophoresis) (Bosilevac and Koohmaraie, 2011; Paddock
et al., 2013). Multiplexed oligonucleotide PCR (MOL-PCR), a
nucleic acid-based assay chemistry capable of the simultaneous
detection of several specificDNA signatures in a high-throughput
single reaction using a multiplex ligation technique, addresses
limitation of both plex level and throughput. MOL-PCR: (1)
does not require multiple rounds of analysis; (2) has minimal
setup and operational costs; (3) is capable of both pathogen
identification and provides additional characterization; and (4) is
easily scalable in high-throughput situations (Deshpande et al.,
2010). The major objective of this study was to develop an
assay utilizing high-throughput MOL-PCR to identify all of
the STEC-8 serogroups while also detecting stx1, stx2, and
eae in a single sample and in a single reaction. We describe
herein, the development and validation of this assay using
blinded and known panels of DNA samples that represented
the STEC-8 serogroups and various toxin gene profiles. This
STEC-8 MOL-PCR assay was highly multiplexed, but more
importantly the underlying chemistry also makes it dynamic
and adaptable to allow inclusion of additional signatures
(serogroups, toxins, etc.) as they are identified as being of
interest to public health. As the impact of STEC associated
illness on public health is explored additional information
on classification will be needed on single samples; this
assay can serve as the backbone for a complex screening
system.
MATERIALS AND METHODS
MOL-PCR Signature Selection
The STEC-8 MOL-PCR assay was designed from probes
developed for multiplex PCR to detect O26, O45, O103, O111,
O121, O145, andO157:H7 serogroups as well as STEC and EHEC
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virulence genes (stx1,stx2, and eae) (Bai et al., 2012; Paddock et al.,
2012). In that work, searches were conducted using BLASTN to
generate forward and reverse primers unique to each virulence
marker: stx1, stx2, and eae (Bai et al., 2012). The primers for
stx1 were designed to detect a sequence common to stx1a, stx1c,
and stx1d, and validated to detect all three subtypes (Bai et al.,
2012). The primers for stx2 were designed and in-silico validated
to detect a sequence common to all stx2 subtypes but stx2f, and
experimentally validated to detect stx2a, stx2b, stx2c, and stx2d,
which were the only subtypes available in the collection (Bai et al.,
2012).
In our work, multiplex PCR primer sequences for
all serogroups as well as virulence genes were searched
against all available genomes in GenBank using BLASTN
(blast.ncbi.nlm.nih.gov). This search was done as a first step to
verify that this section of sequence was truly unique and able
to confer serogroup specificity. Both forward and reverse sets
of primers for each sequence did not return homology outside
of their expected serogroup specific sequences. In most cases,
the forward primer sequence for each marker from the previous
multiplex PCR (Bai et al., 2012; Paddock et al., 2012) work
was used as the basis for probe (MOLigo pair) design for the
MOL-PCR assay.
MOLigo Pair Design
MOLigos were designed using MOLigoDesigner developed at
Los Alamos National Laboratory (LANL) (Gans and Wolinsky,
2008). The tool generates the sequence design for two single
stranded MOLigos (MOLigo-1 and MOLigo-2) for each unique
sequence being targeted. The MOLigo detection event requires
the annealing of two MOLigos adjacent to each other, on the
target DNA. MOLigo-2 included a universal reverse primer
sequence (5′-ACTCGTAGGGAATAAACCGT-3′), followed by a
microsphere specific anti-TAG 24-mer sequence and the site-
specific STEC target DNA sequence on the 3′ end with a total
nucleotide length varying between 61 and 74 bases. MOLigo-1
was synthesized with a phosphorylation tag at its 5′ end followed
by the site-specific STEC DNA sequence and a universal forward
primer sequence (5′-TCTCACTTCTTACTACCGCG-3′) with a
varying total nucleotide length between 36 and 55 bases (Table 1).
The total amplicon (fully ligated MOLigo-1 to MOLigo-2) length
per target varied between 101 and 127 bases with the site-specific
region being between 37 and 63 bases on the target sequence.
MOLigos were designed to be complementary to the desired
conserved sequences in the O-antigen gene cluster unique to each
serogroup of the STEC-8. Each MOLigo pair was designed as the
reverse complement of a unique contiguous sequence previously
TABLE 1 | Sequences for MOLigo pairs with all portions defined.
Serogroup/genea xTAGb IDc Sequenced
O26 rNO26Fwzx958A(+)M1 Phos-ACCCACCCCCCCTAAACTTCTCACTTCTTACTACCGCG
A034 rNO26Fwzx958A(+)M2 ACTCGTAGGGAATAAACCGTtgatatagtagtgaagaaataagtGATACTTTGAACCTTATATCCCAATATAGT
O45 NO45Fwzx377G(+)M1 Phos-TGGACAGCCCACTTGCAGTCTCACTTCTTACTACCGCG
A065 NO45Fwzx377G(+)M2 ACTCGTAGGGAATAAACCGTtgagtaagtttgtatgtttaagtaGCCAAACCAACTATGAACTGTC
O103 NO103Fwzx303G(+)M1 Phos-CCCGTACTTATAATAAAACAACAGGCTCTCACTTCTTACTACCGCG
A038 NO103Fwzx303G(+)M2 ACTCGTAGGGAATAAACCGTagtaagtgttagatagtattgaatTCTGATATTTTACTGGAAAAAAGCACC
O104 M1O104-b62-wzx821G Phos-AATAAAACCTGCGATATCTGCTTCTCACTTCTTACTACCGCG
A062 M2O104-b62-wzx821G ACTCGTAGGGAATAAACCGTtgaaatgtgtatttgtatgtttagGTTGAAATTCTTTGCGCGAC
O111 JBO111Fwzx496C(+)M1 Phos-CACTCTTGTAATTACTTCAAAAAAACATGATTCTCACTTCTTACTACCGCG
A046 JBO111Fwzx496C(+)M2 ACTCGTAGGGAATAAACCGTgtgattgaatagtagattgtttaaGCCATATATTACTATAGAAGCCCAGAG
O121 NO121Fwzx420T(+)M1 Phos-AATATAATGATGAATCTAAGCGTTGTTATAAAAATTCTCACTTCTTACTACCGCG
A027 NO121Fwzx420T(+)M2 ACTCGTAGGGAATAAACCGTaagatgatagttaagtgtaagttaAGTATAACCTTTTACTTTCATGACAGGA
O145 M1O145b35Fwzx98T Phos-AAAGTCGAGCAAGCAAAACATCTCACTTCTTACTACCGCG
A035 M2O145b35Fwzx98T ACTCGTAGGGAATAAACCGTaataagagaattgatatgaagatgCACTCCTAAATCTGTTGATGGTA
O157:H7 NO157FECs2841-578G(+)M1 Phos-CACCTTCACCTGTAGTAATAGTTTTATTTTCTCACTTCTTACTACCGCG
A028 NO157FECs2841-578G(+)M2 ACTCGTAGGGAATAAACCGTgatagatttagaatgaattaagtgTGTCATTCGTGACAACCATTC
stx1 M1stx1-b45-626A Phos-CATCCAGTGTTGTACGAAATCCTCTCACTTCTTACTACCGCG
A045 M2stx1-b45-626A ACTCGTAGGGAATAAACCGTgttagttatgatgaatattgtgtaATAAGAACGCCCACTGAGAT
stx2 M1stx2-b19-565C Phos-GACAGCAGTTATACCACTCTGTCTCACTTCTTACTACCGCG
A019 M2stx2-b19-565C ACTCGTAGGGAATAAACCGTgtgtgttatttgtttgtaaagtatCGGTTTCCATGACAACG
eae eae2120A(+)M1 Phos-TGGTCAGGTCGGGGCGTCTCACTTCTTACTACCGCG
A056 eae2120A(+)M2 ACTCGTAGGGAATAAACCGTaattagaagtaagtagagtttaagTTCCGAAAACATGCTGGCATT
Universal Forward DualBiotin Univ Forwd Primer Dual-Biotin-CGCGGTAGTAAGAAGTGAGA
Universal Reverse Universal Reverse Primer ACTCGTAGGGAATAAACCGT
aSerogroup and virulence marker of MOLigo pair.
bMagPlex-TAG microsphere with anti-TAG sequence.
cMOLigo probe identification name.
dTarget hybridizing sequence (underlined and uppercase), universal forward primer sequence (bold and uppercase), universal reverse primer sequence (italic and uppercase), TAG
sequence (lowercase). Phos is 5′ phosphorylation. Dual-Biotin is a 5′ Dual Biotin label.
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identified as serogroup-specific for each of the STEC-8. The assay
was also designed to detect conserved sequences for stx1, stx2, and
eae at the same time as the STEC-8 serogroups.
MOLigoDesigner uses the nearest-neighbor model for
calculating the melting temperature (Tm) of hybridized
oligonucleotides. The following inputs were used during
MOLigo pair design; ligation Tm = 55
◦C, STEC DNA specific
sequence = 12–45 base pairs, with a maximum Delta Tm =
5◦C, oligonucleotide concentration = 5 nM, monovalent salt
concentration = 60mM, divalent salt concentration = 2mM,
and nucleotide triphosphates concentration = 2μM. During the
design process the various tag sequences and primer sequences
were added to either appropriate MOLigo partner as described
previously.
Once designed, MOLigo pairs were in-silico tested against all-
available genomes in NCBI’s BLAST program to look for possible
interactions of MOLigos with non-target genome sequences. All
MOLigo pairs that returned low non-target interactions (E >
0.002) were then considered to be unique probes for STEC-8
associated DNA sequences. These MOLigo pair sequences were
then tested using NUPACK (NUPACK.org) (Zadeh et al., 2011)
to evaluate interactions between various MOLigo-1/MOLigo-2
pairings, primer-dimers reactions. No interactions were found
with a free energy lower than -2.5 kcal/mol at 50◦C and were
therefore considered to be non-interacting. This check ensured
that the MOLigos could be used in a multiplex reaction and were
compatible.
Integrated DNA Technologies (IDT DNA) (Coralville, IA)
synthesized all finalized MOLigo pairs on a 25–100 nmole scale,
depending on oligonucleotide length, with standard desalting
as the purification method. IDT DNA also synthesized the
universal forward and reverse primers as well as the full-
length control consisting of the full length STEC serogroup O26
MOLigo-1-MOLigo-2 pair synthesized as one unit with a unique
TAG sequence, which was used as a positive control for PCR
amplification. All custom oligonucleotides were reconstituted in
TE buffer (10mM Tris, pH 7.5, and 1mM EDTA, Affymetrix;
Santa Clara, CA) at concentrations of 20μM–200μM. MOLigos
and primers were stored at−20◦C for long-term stability.
MOLigo Ligation to Template DNA
Discrimination of the STEC-8 relevant DNA sequences was
accomplished during the first step, ligation. The ligation reaction
was carried out with either PFU DNA (Agilent Technologies;
Santa Clara, CA) ligase, or Ampligase DNA ligase (Epicentre;
Madison, USA) as they are both thermostable ligases. The ligation
reaction volume was 10μL for capped tube reactions and 20μL
for PCR plate (USA Scientific; Orlanodo, FL) reactions sealed
with TempPlate sealing film (USA Scientific). Regardless of
volume, the final reaction contained 1X Ligase buffer (Epicentre
or Agilent Technologies), individual MOLigos at 4 nM, sheared
UltraPureTM Salmon Sperm DNA (ThermoFisher, Grand Island,
NY) at 0.15mg/mL, and DNA Ligase at 1.25 units (U) per
reaction. Uracil-DNA Glycosylase (ThermoFisher) (UDG) (5
U/μl) was added at 2.5U per reaction to control for amplicon
carry-over from previous experiments. (Longo et al., 1990) The
sealed tubes or plates were run on a thermal cycler (Applied
Biosystems, Foster City, CA) with the following conditions: 37◦C
for 30min followed followed by 3min at 95◦C and then 30 cycles
of 25 s (s) at 95◦C and 50◦C for 2min. The reaction was held at
95◦C for 30min at the end to inactivate the UDG before holding
at 4◦C.
The ligation step, including addition of all non-target DNA,
buffers, and enzymes, was performed inside a PCR hood or dead
air box to prevent any amplicon or target STEC DNA from
contaminating reagent stocks.
Amplification of Detection Event
PCR amplification of the ligation product was performed using a
standard PCR amplification protocol. Briefly, 2μL of the ligation
product was transferred to tubes or a PCR plate containing 8μL
or 18μL of PCRmaster mix. The PCR final reaction contained of
1X Amplitaq Gold buffer (Applied Biosystems; Foster City, CA),
4mMMgCl2, 0.5μMuniversal forward primer, 0.1μMuniversal
reverse primer, dUTP mix (ThermoFisher, Grand Island, NY)
(200μMA, C, G and 400μMU) to work in conjunction with the
UDG in the previous step, and Amplitaq Gold DNA polymerase
(Applied Biosystems; Foster City, CA) at 0.5U/reaction. The PCR
amplificationwas performed in a thermocycler with the following
conditions: 95◦C for 10min followed by 45 cycles: 95◦C for 15 s,
58◦C for 20 s, and 72◦C for 20 s. A 7-min extension at 72◦C
was added after the cycles with a final hold at 4◦C until further
processing.
The addition of the ligation product and any control DNA
(purified or synthetic) to the PCR plate was performed in
a separate hood from the hood where the master mix was
dispensed.
As an additional control for amplicon contamination, the pre-
PCR/ligation laboratory was not re-entered until the next day
once the amplification thermocycling was started in the post-
PCR laboratory. During the post-processing of the amplified
samples there is a high probability of amplicon aerosol
generation, which is easily carried over between laboratories. In
implementing this one-way workflow, contamination from the
high quantity of amplified MOLigo amplicons during PCR was
greatly reduced. One of the goals of this research was to not
only develop an assay for STEC detection, but also to develop
a standardized protocol for implementing MOL-PCR based
detection of STEC for use in public health/testing laboratories.
Capture of Amplified Product to
Microsphere Array
Hybridization of the amplified product to the anti-tag bearing
Luminex MagPlex-TAGTM (Luminex Corp.; Austin, TX)
microspheres was done using a mix of 13 different microspheres;
one for each MOLigo product (STEC-8 along with stx1, stx2,
and eae) as well as an assay positive control and an additional
microsphere that served as either a blank or PCR positive
control. The microsphere mix was made by combining 36μL of
each MagPlex-TAGTM microsphere stock in a microcentrifuge
tube, pelleting the microspheres at 7500 × G for 5min followed
by suspending the pellet in 900μL of 800mM NaCl/50mM
MES buffer (Fisher Bioreagents). Ten microliters of this solution
was added to each well of the PCR product plate giving 1000
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microspheres for each region (13,000 microspheres total) per
reaction well on the plate. The total volume for the hybridization
reaction was 30μL; 20μL PCR product and 10μL microsphere
mix. Hybridization was carried out on a thermal cycler block
with a slow ramp down from 95◦C (95◦C for 3min (min),
85◦C for 1min, 75◦C for 1min, 65◦C for 1min, 55◦C for
1min, 50◦C for 30min, 45◦C for 1min, 40◦C for 1min, 35◦C for
1min, 30◦C for 1min and hold at 25◦C).
Fluorescent Reporter Labeling of Complex
and Analysis
Before analysis on the Luminex R© 100TM/MAGPIX R©, the samples
were placed on a magnetic plate (EMD Millipore; Billerica, MA)
for 5min before being inverted sharply to remove supernatant.
The microsphere pellets in each well were then suspended
in 25μL of 10μg/mL Streptavidin Phycoerythrin (SAPE) (BD
Biosciences; San Jose, CA) in TE buffer and incubated at
room temperature for 30min, protected from light. Following
incubation with the SAPE, the plate was pelleted again on the
magnetic plate as stated above and the pellet was suspended in
100μL of TE buffer and transferred to a standard 96-well plate
for analysis.
The 96-well plate was analyzed on a Luminex R© 100TM or
MAGPIX R©, recording the median fluorescence intensity (MFI)
values for each region with a lower limit of 100 events per region.
Included on the plate was a column of eight no-template controls
to account for any cross reactivity of the MOLigo pairs in the
absence of target DNA. Also included on the plate was a set of
8 process controls consisting of DNA isolates from each STEC-
8 serogroup. These MFI values for the no-template controls and
samples were used as the basis to make a call for “positive” or
“negative” for each target DNA sequence. An exact Wilcoxon
rank sum analysis was done between the eight independent no-
template controls and the three replicates of each sample being
tested.
Statistical Analysis
The small sample sizes used in the assay per test (8 no-template
controls and 3 replicates) were appropriate for applying an
exact Wilcoxon rank-sum statistical test for making “positive” or
“negative” determinations. Non-parametric tests, such as these
are of value in cases where data sets are small, there are non-
matched pairs, and little is known of the distribution of the data
(Whitley and Ball, 2002; Walker and Institute, 2010). Wilcoxon
rank sum was performed by 3 steps, which were automated in
this assay in an Excel macro.
STEC-8 MOL-PCR Assay Optimization
A significant amount of care was used to design the probes
for detecting STEC-8, which relied initially on work done by
Bai et al. (2012) in their multiplex PCR assay development. In
most of that work the wzx (O-antigen-flippase) genes in the O-
antigen (lipopolysaccharide) gene cluster were targeted for O26,
O45, O103, O104, O111, O145, and wbqE (encodes for putative
glycosyl transferase) and wbqF (encodes for putative acetyl
transferase) for O121. STEC O157 was detected using the rfbE
gene, as it identifies the O157 serogroup. Initially each MOLigo
pair was tested individually on its respective serogroup reactive
strain to develop the appropriate ligation and amplification
protocol. Each of these strains also has an associated virulence
profile relative to the specific toxin gene sequences tested in this
assay; stx1, stx2, and eae.
During early testing and validation, each assay product was
divided such that half of the product was visualized on an
agarose gel stained with ethidium bromide and the second
half was hybridized to Luminex microspheres. MOLigoDesigner
produced a MOLigo pair that consisted of a positive (+)
strand MOLigo pair as well as a negative (−) strand (reverse
complement) MOLigo pair. Computational analysis of predicted
MOLigo strands indicated the absence of interactions between
strands, therefore during the protocol optimization step each set
(positive or negative) was evaluated individually against their
complement target DNA from ATCC. STEC serogroup samples
from ATCC were used at 5 × 106 copies of DNA per reaction.
MOLigos were successfully evaluated against their respective
ATCC serogroup by titrating the respective pairs of MOLigos
from 1× 107 copies down to 1× 104 genomic copies of template
DNA.
To confirm the specificity of the STEC-8 MOL-PCR assay,
it was tested against two sets of STEC-8 samples, ATCC and
KSU. Both sets contained all STEC-8 serogroups, and had slightly
different virulence gene profiles. In these tests, the full set
of all 11 MOLigo pairs were combined to perform the fully
multiplexed assay. Figure 1 displays the integer signal-to-noise
ratio of median fluorescence intensity reported for each STEC
DNA sample for each MOL-PCR probe compared to the known
profile. There was agreement between the known and MOL-PCR
reported profiles for both sets of samples tested, except ATCC
STEC O121 (BAA-2219D) reported as being positive for stx1 by
MOL-PCR when it was known to be negative for that virulence
gene.
E. coli and Non-E. coli DNA Used for Assay
Validation
The MOL-PCR STEC-8 assay was evaluated using multiple
panels of DNA samples. Initial development was done on two
independent sets of DNA: samples obtained from the American
Type Culture Collection (ATCC) and samples obtained from
Kansas State University (KSU). Template DNA obtained from
ATCC (Manassas, VA) included the following: BAA-460D
(O157:H7), BAA-2192D (O145:NM), BAA-2193D (O45:H2),
BAA-2196D (O26:H11), BAA-2215D (O103:H11), BAA-2217D
(O146 mislabeled as O111 by ATCC), BAA-2219D (O121:H19),
BAA-2326D (O104:H4), BAA-2440D (O111). This DNAwas well
characterized, purified, and lyophilized. KSU sample strains were
H30 (O26), CDC 96-3285 (O45), CDC 90-3128 (O103), ATCC
BAA-2326 (O104), JB1-95 (O111), CDC 97-3068 (O121), 83-75
(O145), and 380-94 (O157).
The first phase of testing was conducted on a set of 99
reference purified DNA (purified DNA) samples prepared in
the laboratory of R. Moxley, which contained O26 (10), O45
(10), O103 (10), O104 (9), O111 (10), O121 (10), O145 (10),
O157 (10) across a range of H (flagellar) antigens expressing
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FIGURE 1 | STEC-8 MOL-PCR assay evaluated against commercial STEC associated DNA (ATCC) and STEC associated DNA from laboratory cultures
(KSU), reported as signal to noise ratio of median fluorescence intensity. Values were rounded to the nearest integer where zero values were from reported
zero median fluorescence intensity; predicted highest and assay highest values highlighted in blue. (A) ATCC STEC DNA predicted interactions agreed with the (B)
corresponding assay results, with the exception of O121 (BAA-2219D) stx1 reporting as present when known not to be. (C) KSU STEC DNA predicted interactions
were in complete agreement with the assay results (D) for the KSU samples.
mixed combinations of virulence genes. This set of DNA
represents a mix of isolates from both human and bovine
fecal samples. In addition to samples that were STEC-8, there
were 6 samples that were O antigen classified as O101, O8,
O142, O150, O104 (non-STEC), and O124. Also included in
this set were 14 samples that were STEC unrelated, used here
as an exclusivity panel: Aeromonas hydrophila, Enterobacter
cloacae, Enterococcus faecalis, Klebsiella pneumoniae, Morganella
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morganii, Proteus mirabilis, Proteus vulgaris, Providencia rettgeri,
Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus
aureus, Yersinia enterocolitica, Streptococcus gallolyticus,
and Salmonella Typhimurium. This exclusivity panel is a
representative collection of related organisms that are commonly
found in fecal samples and serve as an appropriate analog for
interactions of the STEC-8 MOL-PCR with non-target genomic
DNA (non-reactive). The second phase of testing was conducted
on a panel of 144 DNA samples that were blinded and provided
by the T. Nagaraja laboratory. These represented isolates from a
diverse set of samples obtained from human infants, male and
female adult humans, rabbit, bovine (cow and calf), and cattle
feed. For all tests the complete STEC-8 MOL-PCR 11-plex was
used.
RESULTS
Evaluation of Reference Panel
The reference samples were analyzed with the STEC-8 MOL-
PCR assay and used to train the exact Wilcoxon algorithm for
making semi-automated calls for the serogroup and virulence
gene profile. The exclusivity panel was used to develop the
thresholds for determining the positivity of a test sample. The
mean signal-to-noise ratio for each sample, across all markers,
was calculated and used as a basis to adapt the exact Wilcoxon
rank sum test.
Evaluation of Exclusivity Panel
When the STEC-8 MOL-PCR assay was tested using the
exclusivity panel, 80.3% of 168 possible combinations of
MOLigos and template DNA returned a mean signal-to-noise
ratio less than 1.5 (Figure 2). In the exclusivity panel, E. faecalis,
K. pneumoniae, M. morganii, P. rettgeri, and S. aureus each
contained a large number of signal-to-noise values above 1.5
for various MOL-PCR probes. In addition to the traditional
Wilcoxon Exact Rank Sum test, a second condition of a signal-
to-noise ratio above 1.5 was implemented into the algorithm
for each data point reported from this point onward. A low
signal-to-noise threshold of 1.5 was implemented to have limited
impact on the statistical analysis done by the Wilcoxon test.
Post two-step algorithm processing of the panel Enterococcus
faecalis, Klebsiella pneumonia, Morganella morganii Providencia
rettgeri, and Staphylococcus aureus returned STEC serogroup
positive results. These 5 samples were a mix of Gram-negative
and Gram-positive bacteria.
Evaluation of STEC Reference Panel
The STEC reference samples from the Moxley laboratory were
analyzed with the addition of the signal-to-noise threshold along
with Wilcoxon to account for any small amount of interaction
with background that could be present in the purified samples. In
order for a positive call to be made, both criteria (>1.5 signal-to-
noise ratio and Wilcoxon critical value) were required to be met.
The concentration of the reference purified STEC DNA samples
tested was between 10 and 30 ng STEC DNA per reaction,
which computes to 1.5 × 106 to 5 × 106 genomic copies per
reaction. As with the initial test samples, all reactions were run in
triplicate on a single plate to account for variations in reactions.
The data showed (Supplemental Table 1) that the serogroup
calls agreed with the known serogroups 63 out of the 79 STEC
FIGURE 2 | Exclusivity panel of STEC unrelated DNA samples from bacterium as noted in figure evaluated with the STEC-8 MOL-PCR assay. The
evaluation 11-plex is color coded on the figure with corresponding signal-to-noise ratio being shown. The majority of the marker responses are below 1.5 signal to
noise.
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samples. The virulence gene profile data provided was incomplete
for the isolates tested, i.e., presence of stx1, stx2, and eae was
not known. Independent searches performed on the Michigan
State University STEC database (www.shigatox.net) revealed
incomplete data for virulence gene profiles for some strains.
Literature searches were also done to obtain additional gene
information missing from the original documentation provided
(Stromberg et al., 2015; Toro et al., 2015). The missing data for
stx1, stx2, and eae DNA samples in this set has been noted in
Supplemental Table 1; the additional gene profile information
identified has also been added. As a result of missing information,
it was difficult to determine the specificity of the assay as it
pertains to the virulence gene profiles for these samples. The
STEC-8 MOL-PCR assay correctly identified 202 out of the 210
known virulence genes present in the 79 STEC DNA samples.
The assay identified additional serogroups along with the
known serogroups for the following isolates: JB1-95, 0201 9611,
MI01-88, 8266-1, and G5508, which results in a serogroup
diagnostic specificity of 94% on the low end to 100% on the
high end (Table 2). Included in this percentage were cases where
the combined assay and algorithm returned no serogroup, when
the test should have detected one of the STEC-8: MDCH-4
(excluded), KDHE 47, DEC10I (87-1713), 1:361, 1553-1, DA-
37, 10C-3114 (excluded), 2002-3211, KDHE 55, 314-S, 86-24, or
403-3.
MDCH-4 was originally reported as serotype O121:H19, but
it was later discovered to be O113, which was corrected in
Supplemental Table 1. ATCC originally reported 10C-3114 as
O111:H8, and as such included that strain in its “Big-Six” non-
O157 genomic DNA panel as its reference O111 serogroup.
ATCC reported this was an error, and now lists 10C-3114
as serogroup O146. The MOL-PCR STEC-8 assay returned
no serogroup for these two isolates, which is consistent with
what was expected. The assay was able to identify a complete
serogroup-virulence gene profile that matched the known profile
62 out the 79 (78.5%) STEC samples. These results demonstrated
TABLE 2 | Diagnostic specificity of STEC-8 MOL-PCR assay on STEC DNA
isolates.
Signature Reference DNA Panela Blinded DNA Panelb
O26 97.75% (87/89)c 100.00% (115/115)
O45 97.75% (87/89) 99.29% (139/140)
O103 94.38% (84/89) 96.23% (102/106)
O104 97.75% (87/89) 100.00% (125/125)
O111 96.67% (87/90) 99.12% (113/114)
O121 94.44% (85/90) 100.00% (135/135)
O145 100.00% (89/89) 100.00% (131/131)
O157 97.75% (87/89) 100.00% (141/141)
stxI 86.49% (32/37) 76.92% (20/26)
stx2 87.50% (49/56) 98.17% (107/109)
eae 80.56% (29/36) 96.55% (28/29)
aReference DNA panel from R. Moxley laboratory.
bBlinded DNA panel from T. Nagaraja laboratory.
c(m/n) ratio of true negative samples to all samples known to be negative.
that the STEC-8 MOL-PCR assay was capable of screening
samples on a large scale with the added advantage of automated
data analysis.
Evaluation of Blinded Samples
Further testing of the MOL-PCR assay was conducted using a
set of 144 blinded samples provided by the Nagaraja laboratory
(KSU). These 144 blinded samples were from supernatant lysates
from pure cultures of STEC-8 strains that were boiled and
centrifuge separated. Supplemental Table 2 shows a list of all
144 samples whose MOL-PCR results were sent to the laboratory
at KSU for comparison to their multiplex-PCR assay (the gold
standard) results; KSU identification is also provided in this list.
In six of the 144 samples the assay returned more than a single
serogroup. There were also instances (total of 8 of the 144) where
the STEC-8MOL-PCR assay did not return any serogroup and/or
virulence gene.
Given the information that was provided about these samples
(serogroup and presence of stx1, stx2, and eae as reported
by the Nagaraja laboratory) it is possible to determine the
diagnostic specificity of the STEC-8 MOL-PCR assay. There was
an underrepresentation of serogroups O45 (4), O121 (9), and
O157 (3) in this DNA panel. Specificity for each MOLigo pair
was calculated as the percentage of the number of true negatives
identified from the sum of the number of true negatives and the
number of false positives, or number of actual negatives in the
panel.Table 2 shows that specificity of eachMOLigo pair was 76–
100% depending on the MOLigo pair. The STEC-8 MOL-PCR
assay identified the complete known serogroup-virulence gene
profile with 86.1% (124/144) accuracy.
Table 3 shows the details of the incorrectly identified samples
from both the reference set and the 144 blinded set, with the
following exceptions: the exclusivity panel was not included, and
if a particular sample’s virulence gene was unknown then any
virulence gene identified for that sample was considered correct.
The STEC-8 MOL-PCR assay identified an additional serogroup
11 times and completely missed the serogroup 14 times from
the combined set of 223 STEC samples. The virulence gene eae
had the lowest number of false positives with 2 occurrences,
compared to 6 for stx1 and 4 for stx2 out of the combined
223 STEC samples. The STEC-8 MOL-PCR assay missed the
complete gene profile or missed one out of the three virulence
genes 6 times from the 223 STEC samples.
DISCUSSION
Several nucleic acid assays are currently available for detection
of STEC with multiple targets in a single reaction (Beutin et al.,
2009; Bai et al., 2012; Noll et al., 2015). In many of these assays,
detection of STEC is limited to a set of virulence related genes as
the primary tool for early detection. The general trend displayed
across many of these assays is that the virulence gene profile (e.g.,
stx1, stx2, eae) is the most important, followed by the ability to
identify the STEC serogroup. There are, of course, nucleic acid
assays that detect virulence genes along with STEC serogroups,
but often they are run as two parallel assays (Conrad et al., 2014)
and are limited in plex level (Bai et al., 2012). The benefit of
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TABLE 3 | Detailed examination of incorrect identifications.
Sample ID Additional serogroupsa Missed serogroupb Incorrect stx1
c Incorrect stx2
d Incorrect eaee Missed genef
STEC REFERENCE SAMPLES
KDHE 47 X X
DEC10I (87-1713)
1:361 X
1553-1 X
DA-37 X X
JB1-95 X
2002-3211 X
KDHE 55 X X
314-S X
86-24 X
88-1577 X
403-3 X X X
0201 9611 X
MI01-88 X
2011-5-383-1 X
8266-1 X
G5508 X
144 BLINDED STEC SAMPLES
Blinded 06 X
Blinded 10 X X
Blinded 127 X X
Blinded 139 X
Blinded 14 X
Blinded 16 X
Blinded 21 X
Blinded 49 X
Blinded 70 X
Blinded 73 X
Blinded 74 X
Blinded 85 X X
Blinded 89 X
Blinded 90 X
Blinded 91 X
Blinded 92 X
Blinded 93 X
Blinded 96 X
Blinded 97 X
Sum 11 of 223 14 of 223 6 of 223 4 of 223 2 of 263 6 of 223
aAdditional serogroups along with the correct serogroup identified by the STEC-8 MOL-PCR assay.
bNo serogroup identified by the STEC-8 MOL-PCR.
cstx1 identified by the STEC-8 MOL-PCR assay when it is known not to be present.
dstx2 identified by the STEC-8 MOL-PCR assay when it is known not to be present.
eeae identified by the STEC-8 MOL-PCR assay when it is known not to be present.
f Any virulence genes were not identified by the STEC-8 MOL-PCR assay.
detecting both serogroup and virulence gene profile in a single
assay is one of monitoring samples during possible outbreaks
where serogroups and virulence profiles can be used in early
tracking statistics. Our STEC-8 MOL-PCR assay was capable
of detecting both the serogroup of the eight important STEC
serogroups as well as stx1, stx2, and eae, with the benefit of still
being able to expand the assay to up to 50 unique DNA sequences
of interest as they are identified.
Our goal for developing this STEC-8 MOL-PCR assay was
to enable high-throughput, high-information content (multiplex
analysis) screening of samples for STEC. The assay is intended to
be utilized on samples that have already undergone enrichment
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culture, a standard protocol in testing labs (Gould et al., 2009)
to account for problems with complex microbial backgrounds
for some of the matrices along the beef production chain (e.g.,
fecal samples, carcass samples, hide samples, etc.). It is of greater
interest that the specificity of serogroup along with virulence
profile be identified. The STEC-8 MOL-PCR assay that we have
described herein is capable of performing this task reliably, which
adds to the ability to detect STEC in a large number of samples
collected along the beef production chain. We have shown the
ability to perform a single tube 11-plex assay, screening STEC-
8 (O26, O45, O103, O104, O111, O121, O145, O157) along with
the 3 major virulence genes (stx1, stx2, and eae) on as many as 24
unique samples run in triplicate in 1 day producing data with a
high level of confidence.
We conducted a large-scale sample analysis with two groups of
STEC and STEC associated samples. In the first reference panel
set we were able to identify a complete STEC profile across the
major serogroups of interest in the United States 78.5% (62/79)
of the time and 86.1% (124/144) in the blinded panel. It was
shown that even in cases where serogroup or gene identification
was initially misrepresented, the assay was still able to make a
correct identification utilizing the modified exact Wilcoxon rank
sum algorithm with the assay design. It is our hope that this work
will help provide useful information to the larger community of
STEC research.
Every effort was made to collect a reference set of samples
with a high degree of known specifications to evaluate the
performance of our assay. A large number of STEC samples
are readily available, but the serogroup and virulence identity
for these samples is not complete or possibly misidentified.
Many of the STEC strains identified have not been sequenced,
which makes absolute identification difficult. These strains
are generally identified using real-time multiplex PCR or
multiplex PCR. Many of the commercial detection assays have
a specificity that ranges from 71 to 100% (Parsons et al.,
2016), which aligns with the performance of our assay at
78–86%. We believe our assay is comparable to these assays,
with the added benefits of high-throughput sampling and
complete serogroup-toxin profile in a single assay. Much
work went into researching gene identity for isolates where
this information was not known or where the reported
information was in question. Literature data for some STEC
isolates did not always match database values making correct
identifications difficult. The MOL-PCR assay was able to
identify the presence of virulence genes (eae) that had not
been previously documented. Ten samples were identified by
the assay as containing eae, which was later confirmed by
multiplex PCR. Additionally, the assay identified blinded sample
44 (05EN000712) as having both O103 and O145, which was also
confirmed.
We are currently evaluating the limit of detection for the
full 11-plex STEC-8 MOL-PCR assay as well as examining the
effect of complex matrices such as bovine feces in the absence of
enrichment on the assay performance (Paddock et al., 2012).
Current guidance from the Centers for Disease Control and
Prevention (CDC) for STEC detection and diagnosis states that
human fecal samples suspect for STEC are first plated on O157
STEC selective and differential medium. Any phenotypically
suspect colonies are then tested by latex agglutination for O157
antigen. If no phenotypically suspect colonies are detected, then
the fecal sample is plated on less-selective medium and colonies
from that plate are tested for Stx using appropriate methods,
including but not limited to stx gene PCR. If the stx gene
PCR, or comparable test, is confirmed positive for Stx then the
sample is further characterized using PCR for stx1 and stx2 genes
and at this point it is also tested for serogroups O26, O45,
O103, O111, O121, O145, or O157 (Gould et al., 2009). This
series of tests take a total of 2–3 days if all steps are carried
out.
Clinical laboratories currently test for O157 STEC through
culture, and send suspect non-O157 samples to public health
laboratories, which utilize the testing process outlined above.
These testing procedures are very amenable to integration of
the STEC-8 MOL-PCR assay as it both identifies stx1 and
stx2 as well as eae and each of the suggested serogroups in
a single test on enriched cultures. Adding in the MOL-PCR
process would be of particular benefit in cases where large-scale
screening is required due to a STEC outbreak and/or food recall.
It also has the benefit of reducing the total characterization
time by up to 2 days by eliminating the several culturing steps
currently required. Implementation of the STEC-8 MOL-PCR
assay in a clinical or public health laboratory that is currently
performing other PCR based assays would only require one
additional piece of equipment which is essentially a standard flow
cytometer.
One of the benefits to the MOL-PCR assay is the relative
ease for selective modification as necessary. This assay has had
a few MOLigo pair redesigns to switch certain MagPlex-TAGTM
beads as well as target DNA sequence redesigns. The changes
to these MOLigo pairs did not require the reaction conditions
or the non-modified MOLigo pairs to be altered. If additional
signatures (serogroup, toxin, etc.) of interest are identified it
will be important to rapidly expand to higher level multiplexing,
which is possible with the MOL-PCR assay as it will require
minimal reconfiguration. The Luminex R© MAGPIX R© instrument
is capable of testing for 50 unique signatures or markers, of
which we have used only 11. We have discussed here additional
components that are relevant to add to the assay, including
ehxA (enterohemolysin) signatures and performing eae (Madic
et al., 2010) and stx2 (Wang et al., 2002) subtyping for further
characterization of samples.
Nucleic acid detection schemes like multiplex real-time
PCR and other multiplex PCR technologies (the current gold
standards for STEC molecular diagnostics) cannot process large
sets of samples containing large amounts of information in a
short period of time. This is primarily due to limitations in the
information readout technology used by the process (Deshpande
and White, 2012). The STEC-8 MOL-PCR assay was designed
to have a robust design, which when run as described produced
results with limited amounts of false positive and false negatives
on 24 unique samples in single day. Reduction from triplicate
sample processing to a single replicate would make it possible
to process 80–88 samples for all 11 unique STEC associated
signatures in single day.
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